Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 77 clinical trials
Examination of Radiographic Progression Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

and physiotherapy which are oft insufficient. Treatment with the TNF-alpha blocking agent infliximab was shown to have definite clinical efficacy in patients with active AS on a short- and a

steroidal anti-inflammatory drugs
infliximab
anti-tumor necrosis factor therapy
tumor necrosis factor alpha
NSAID
  • 51 views
  • 07 Nov, 2020
  • 8 locations
Topical Infliximab for Sterile Corneal Melt

necrolysis or mucous membrane pemphigoid. Infliximab is an antibody against tumour necrosis factor alpha and has been used to treat or prevent corneal melt in certain patients with inflammatory of

  • 3 views
  • 03 Feb, 2021
  • 2 locations
Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS)

This study will evaluate the Efficacy and Safety of Infliximab versus Cyclophosphamide in Subjects with Idiopathic Refractory Scleritis. The term scleritis describes a chronic

  • 0 views
  • 24 Jan, 2021
  • 1 location
Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis

The purpose of this study is to establish whether RA patients with moderate to severe disease activity with unsustainable response to infliximab 3 mg/kg every 8 weeks have better efficacy

infliximab
adalimumab
  • 35 views
  • 07 Nov, 2020
  • 5 locations
Efficacy of Remission-induction Regimen With Infliximab for Severe Extrathoracic Sarcoidosis (EFIRTES)

The present study was designed to assess the efficacy of infliximab in a 2-period study : An initial period with comparison of infliximab versus placebo and allowing the

  • 0 views
  • 23 Jan, 2021
  • 2 locations
Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis

rheumatoid arthritis. Etanercept is a fusion protein with TNF receptor type II p75 and IgG1 Fc fragment, whereas adalimumab, infliximab, and golimumab are monoclonal antibodies. Certolizumab is a fusion

steroidal anti-inflammatory drugs
DMARD
infliximab
fusion protein
rheumatoid arthritis
  • 17 views
  • 25 Jan, 2021
  • 26 locations
CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis

This is Phase 3, Randomized, Placebo-controlled study to demonstrate superiority of CT-P13 over Placebo SC in Patients With Moderately to Severely Active Ulcerative Colitis

infliximab
  • 0 views
  • 13 May, 2021
  • 1 location
CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease

This is Phase 3, Randomized, Placebo-controlled study to demonstrate superiority of CT-P13 over Placebo SC in Patients With Moderately to Severely Active Crohn's Disease

infliximab
  • 2 views
  • 13 May, 2021
  • 1 location
Randomised Evaluation of COVID-19 Therapy

), Convalescent plasma, Synthetic neutralizing antibodies (REGN-COV2), Tocilizumab, Aspirin, Baricitinib, Infliximab or Anakinra (children only) prevents death in patients with COVID-19.

covid-19
corticosteroids
lopinavir
azithromycin
hydroxychloroquine
  • 0 views
  • 13 May, 2021
  • 3 locations
Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).

The role of steroids in the treatment of severe ulcerative colitis (UC) exacerbation is well established and recommended by professional societies. Similarly, 5-aminosalycilates (5-ASA) agents in the form of mesalamine/mesalzine are well established proven therapy in mild-moderate UC, and the combination of oral 5-ASA with topical (per-rectal enema) 5-ASA was …

mesalamine
thiopurines
enemas
corticosteroids
  • 6 views
  • 16 Apr, 2021
  • 6 locations